Tag: Hulio
Biocon Biologics debuts biosimilar HULIO in US market
In a significant development for healthcare accessibility, Biocon Biologics Ltd (BBL), a subsidiary of Biocon, announced the availability of its biosimilar injection, HULIO (adalimumab-fkjp), in ... Read More
Mylan launches Humira biosimilar Hulio across Europe
Mylan has launched Hulio, a biosimilar to AbbVie's Humira (adalimumab), in major markets in Europe, a month after its approval from the European Commission for ... Read More